RT Journal Article
SR Electronic
T1 Race-ethnicity and Perceptional Determinants of COVID-19 Vaccination Intentions: A Cross-sectional Study Among Health Workers and the General Population in the San Francisco Bay Area
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.26.21255893
DO 10.1101/2021.04.26.21255893
A1 Weng, Yingjie
A1 Lu, Di
A1 Bollyky, Jenna
A1 Jain, Vivek
A1 Desai, Manisha
A1 Lindan, Christina
A1 Boothroyd, Derek
A1 Judson, Timothy
A1 Doernberg, Sarah B.
A1 Holubar, Marisa
A1 Sample, Hannah
A1 Huang, Beatrice
A1 Maldonado, Yvonne
A1 Rutherford, George W.
A1 Grumbach, Kevin
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/07/01/2021.04.26.21255893.abstract
AB Objective To compare intention to receive COVID-19 vaccination by race-ethnicity, to identify perceptional factors that may mediate the association between race-ethnicity and intention to receive the vaccine, and to identify the demographic and perceptional factors most strongly predictive of intention to receive a vaccine.Design Cross-sectional survey conducted from November, 2020 to January, 2021, nested within two longitudinal cohort studies of prevalence and incidence of SARS CoV-2 among the general population and healthcare workers.Study Cohort 3,161 participants in the Track COVID cohort (a population-based sample of adults) and 1,803 participants in the CHART Study cohort (a cohort of employees at three large medical centers).Results Rates of high vaccine willingness were significantly lower among Black (45.3%), Latinx (62.5%), Asian (65%), multi-racial (67.2%), and other race (61.0%) respondents than among white respondents (77.6%). Black, Latinx, and Asian respondents were significantly more likely than white respondents to endorse reasons to not get vaccinated, especially lack of trust. Participants’ motivations and concerns about COVID-19 vaccination only partially explained racial-ethnic differences in vaccination willingness. Being a health worker in the CHART cohort and concern about a rushed government vaccine approval process were the two most important factors predicting vaccination intention.Conclusions Special efforts are required to reach historically marginalized racial-ethnic communities to support informed decision-making about COVID-19 vaccination. These campaigns must acknowledge the history of racism in biomedical research and health care delivery that has degraded the trustworthiness of health and medical science institutions among non-white population and may continue to undermine confidence in COVID-19 vaccines.Competing Interest StatementThe authors have declared no competing interest.Funding Statement This work was supported by the Chan Zuckerberg Initiative. Dr. Grumbach's effort was partly supported by a grant from the National Institutes of Health, Community Engagement Alliance Against COVID-19 Disparities program (21-312-0217571-66106L). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The TrackCOVID study was designated as a public health surveillance study and not human subjects research under 45 CFR 46.102(l) by Stanford University School of Medicine Administrative Panel on Human Subjects in Medical Research and UCSF Institutional Review Board; the CHART study protocol was approved by the UCSF Institutional Review Board and the Stanford University School of Medicine Panel on Human Subjects in Medical Research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnalytical data will be available with the approval of the California Pandemic Consortium upon request.